Swedish Orphan Biovitrum AB (Sobi) has terminated discussions over the sale of the company's Partner Products business. The decision comes just a few weeks after the Swedish firm appointed a new CEO, Guido Oelkers, to replace Geoffrey McDonough.
The Partner Products division offers a distribution platform for niche medicines in Europe, the Middle East, North Africa and Russia....
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?